Materials & methods: Prospective study on 58 patients with stages II-III gastric adenocarcinoma, underwent distal gastrectomy and D1 or D2 dissection, completed post operative chemoradiation therapy with capecitabine and 4 - 6 cycles with EOX regimen at Oncology center of Hue central hospital from 01/2013 to 12/2015.